EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real‐World Study

Yizhen Chen, Hangdong Jia, Rong Ye, Zhenyuan Zhou, Weijie Chen, Ming Zheng, Yuanyuan Zheng

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.13785 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Yizhen Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Fujian Key Laboratory of Geriatrics Diseases, Fujian Provincial Center for Geriatrics, Fujian Provincial Hospital, …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoadjuvant Therapy, Intra-Abdominal Fat, Liver Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds for Science and Technology Innovation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Visceral obesity (VO), associated with excessive visceral adipose tissue (VAT), has been extensively studied in cancer. However, whether low VAT can predict the prognosis of colorectal liver metastases (CRLM) undergoing neoadjuvant chemotherapy (NAC) remains unknown.

Methods

This multicentre real‐world cohort study analysed data from initially resectable CRLM patients who received NAC. The predictive effect of VAT on progression‐free survival (PFS) and overall survival (OS) was evaluated using restricted cubic splines (RCS). VAT was categorized into low/normal VAT and VO groups using X‐tile. The prognostic differences were further assessed through Kaplan–Meier (KM) analysis. The impact of changes in VAT (ΔVAT) after NAC was evaluated.

Results

Among 1524 CRLM patients, 1105 patients (72.51%) were under 65 years old, with a median VAT of 84.00 (36.24–148.00) cm 2 . Of all patients, 804 (52.76%) were female. A U‐shaped nonlinear relationship was observed between VAT and both PFS/OS ( p < 0.001). Compared with the normal VAT, both low VAT and VO groups showed worsened PFS and OS ( p < 0.05). The 3‐year PFS rate was 31.6%, 69.0% and 42.0% in the low, normal VAT and VO groups ( p < 0.05). The 3‐year OS rate was 76.4%, 88.9% and 79.4% in the low, normal VAT and VO groups ( p < 0.05). There was also a nonlinear relationship between VAT and NAC‐related adverse events, objective response rate and postoperative complications ( p < 0.001). An increase in ΔVAT in the low VAT group was associated with better PFS and OS ( p < 0.05). In the VO group, both increases and decreases in ΔVAT were associated with worsened PFS and OS ( p < 0.05).

Conclusions

This study is the first to reveal that low VAT and VO can predict PFS and OS in CRLM patients undergoing NAC. Baseline VAT and ΔVAT may serve as important indicators for risk stratification and personalized treatment in CRLM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNeoadjuvant TherapyIntra-Abdominal FatLiver NeoplasmsHumansFemaleMaleMiddle AgedAgedPrognosisTreatment OutcomeAdult

Stichwörter der Autor:innen

colorectal cancerliver metastasisneoadjuvant chemotherapyvisceral adipose tissuevisceral obesity

Autor:innen und Institutionen

  • Department of Geriatric Medicine, Fujian Key Laboratory of Geriatrics Diseases, Fujian Provincial Center for Geriatrics, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou…
  • General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Z…
  • Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
  • Anorectal Surgical Department, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
  • Department of Hepatobiliary Pancreatic Surgery, The First Hospital of PuTian City, Putian, Fujian, China.

Förderung

  • Joint Funds for Science and Technology Innovation of Fujian Province

Zitieren

APA

Chen, Y., Jia, H., Ye, R., Zhou, Z., Chen, W., Zheng, M., & Zheng, Y. (2025). Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real‐World Study. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13785

Vancouver

Chen Y, Jia H, Ye R, Zhou Z, Chen W, Zheng M, et al. Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real‐World Study. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13785

BibTeX
@article{Chen2025,
  author = {Chen, Yizhen and Jia, Hangdong and Ye, Rong and Zhou, Zhenyuan and Chen, Weijie and Zheng, Ming and Zheng, Yuanyuan},
  title = {Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real‐World Study},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.13785}
}
Kostenlos starten →